The fact that serum GAL-1 levels are significantly higher in HGGs than in LGGs increases the potential of serum GAL-1 levels as a prognostic marker for the diagnosis and follow-up of gliomas in older age groups. This evidence concerns the gene LGALS1 and central nervous system cancer.